Literature DB >> 6605377

B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.

H Jyonouchi, P W Kincade, R A Good, M E Gershwin.   

Abstract

As adults, NZB mice have a severe deficiency of identifiable precursors of B lymphocytes, but this is preceded by a time when B cells and their immediate precursors are present in bone marrow in elevated numbers. Our present studies indicate that the final stages of B cell formation may be proceeding at a greater than normal rate at 4 wk of age. At this time, large numbers of sIg- B cell precursors can be identified in NZB but not in normal CBA/H or DBA/2 marrow that can respond to mitogens in semisolid agar cultures without preculture. Colony formation by these precursors was dependent on the presence of Sephadex G-10-adherent cells in the suspensions. In this respect, 4-wk-old NZB marrow was similar to spleen and liver of normal CBA/H newborn mice. Mixing experiments suggested that hyperactive regulatory cells present in young NZB marrow may promote functional maturation of normal pre-B cells from CBA/H or DBA/2 mice. In addition, potent substances present in the serum of young but not older NZB mice produced the same effect. Factor-mediated enhancement of clonal proliferation by sIg- precursors was not dependent on adherent cells and required more than brief exposure of the cells to young NZB serum. These are all indications that abnormalities of B lineage differentiation in young NZB marrow may be attributable to microenvironmental elements. Congeneic, B cell-deficient NZB.xid mice, however, lacked hyperactive regulatory cell function and serum factors that characterize NZB mice of this age. A study was also made of B cell precursors in newborn spleen and liver of NZB mice, and abnormal shifts of populations of B lineage cells were already present by that time. These observations support previous contentions that humoral immunity is precocious and abnormally regulated in NZB mice.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605377

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone.

Authors:  J Ohmori; T Ezaki; M Kotani
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

2.  Peritoneal B cells regulate the numbers of allotype-matched pre-B and B cells in bone marrow.

Authors:  M A Marcos; A Sundblad; E Malenchère; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  Qualitative difference of anti-DNA antibody-producing cell precursors in the pre-immune B cell repertoire between normal and lupus-prone mice.

Authors:  K Iwai; T Tsubata; Y Katsura; S Kumagai; H Imura
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 4.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

5.  Influence of dietary energy restriction on the numbers and proportions of Ly-1+ B lymphocytes in autoimmunity-prone mice.

Authors:  M Ogura; H Ogura; S Ikehara; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Morphologic analysis of long-term bone marrow cultures that support B-lymphopoiesis or myelopoiesis.

Authors:  K Dorshkind; L Schouest; W H Fletcher
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

7.  Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.

Authors:  D M Klinman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

8.  Precocious and enhanced functional maturation of B lineage cells in New Zealand Black mice during embryonic development.

Authors:  H Jyonouchi; P W Kincade
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

9.  Suppression of B lymphopoiesis during normal pregnancy.

Authors:  K L Medina; G Smithson; P W Kincade
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.